Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

N K El-mallawany; L Geller; C M Bollard; B Wistinghausen; F Mussai; A S Wayne; B Alobeid; M S Cairo

doi:10.1038/bmt.2010.176

Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

N K El-mallawany, L Geller, C M Bollard, B Wistinghausen, F Mussai, A S Wayne, B Alobeid, M S Cairo

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	759-761
Journal	Bone Marrow Transplantation
Volume	46
Issue number	5
DOIs	https://doi.org/10.1038/bmt.2010.176
Publication status	Published - 1 May 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bmt.2010.176

Cite this

El-mallawany, N. K., Geller, L., Bollard, C. M., Wistinghausen, B., Mussai, F., Wayne, A. S., Alobeid, B., & Cairo, M. S. (2011). Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplantation, 46(5), 759-761. https://doi.org/10.1038/bmt.2010.176

@article{4335a64b56ca4f0d900b9518fc074ff3,

title = "Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy",

author = "El-mallawany, {N K} and L Geller and Bollard, {C M} and B Wistinghausen and F Mussai and Wayne, {A S} and B Alobeid and Cairo, {M S}",

year = "2011",

month = may,

day = "1",

doi = "10.1038/bmt.2010.176",

language = "English",

volume = "46",

pages = "759--761",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "5",

}

El-mallawany, NK, Geller, L, Bollard, CM, Wistinghausen, B, Mussai, F, Wayne, AS, Alobeid, B & Cairo, MS 2011, 'Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy', Bone Marrow Transplantation, vol. 46, no. 5, pp. 759-761. https://doi.org/10.1038/bmt.2010.176

Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. / El-mallawany, N K; Geller, L; Bollard, C M et al.
In: Bone Marrow Transplantation, Vol. 46, No. 5, 01.05.2011, p. 759-761.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

AU - El-mallawany, N K

AU - Geller, L

AU - Bollard, C M

AU - Wistinghausen, B

AU - Mussai, F

AU - Wayne, A S

AU - Alobeid, B

AU - Cairo, M S

PY - 2011/5/1

Y1 - 2011/5/1

U2 - 10.1038/bmt.2010.176

DO - 10.1038/bmt.2010.176

M3 - Article

SN - 0268-3369

VL - 46

SP - 759

EP - 761

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 5

ER -

El-mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS et al. Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplantation. 2011 May 1;46(5):759-761. doi: 10.1038/bmt.2010.176